Meridian Bioscience News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.01.23	SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience (PR Newswire)
25.01.23	DoubleVerify Holdings to Join S&P SmallCap 600 (PR Newswire)
12.12.22	Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger (PR Newswire)
22.11.22	MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS (PR Newswire)
26.09.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TMX, VIVO, RFP, SBTX (PR Newswire)
14.09.22	SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVO, SAVE, AAWW, MNRL (PR Newswire)
29.08.22	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, MANT, VIVO, HNGR (PR Newswire)
22.08.22	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, VIVO, EGY, STCN (PR Newswire)
15.08.22	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, VIVO, HNGR, CMAX (PR Newswire)
08.08.22	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ONEM, HNGR (PR Newswire)
05.08.22	MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS (PR Newswire)
04.08.22	Ausblick: Meridian Bioscience zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
01.08.22	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, VIVO, LJPC, SMED (PR Newswire)
29.07.22	Meridian Bioscience Gets FDA Re-authorization Of EUA For Revogene SARS-CoV-2 Molecular Assay (RTTNews)
29.07.22	Meridian Obtains Re-Authorization From FDA For Revogene SARS-CoV-2 Molecular Assay (RTTNews)
29.07.22	Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay (PR Newswire)
27.07.22	INVESTIGATION ALERT: Halper Sadeh LLP Investigates ZEN, LJPC, VIVO, PCSB (PR Newswire)
21.07.22	Erste Schätzungen: Meridian Bioscience stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
18.07.22	INVESTIGATION ALERT: Halper Sadeh LLP Investigates VIVO, SMED, U (PR Newswire)
11.07.22	INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ZEN, GRRB, EPZM (PR Newswire)
07.07.22	Meridian Bioscience Agrees To Be Taken Private By SD Biosensor And SJL Partners In $1.53 Bln Deal (RTTNews)
07.07.22	Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction (PR Newswire)
07.07.22	Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter (PR Newswire)
20.06.22	Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays (PR Newswire)
26.05.22	Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests (PR Newswire)
23.05.22	Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference (PR Newswire)
17.05.22	Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays (PR Newswire)
06.05.22	MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS (PR Newswire)
05.05.22	Ausblick: Meridian Bioscience präsentiert Quartalsergebnisse (finanzen.net)
02.05.22	Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities (PR Newswire)
21.04.22	Erste Schätzungen: Meridian Bioscience informiert über die jüngsten Quartalsergebnisse (finanzen.net)
07.04.22	Meridian Bioscience Announces Preliminary Net Revenues Results for Fiscal 2022 Second Quarter (PR Newswire)
29.03.22	Meridian Bioscience Launches Lyo-Ready™ qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection (PR Newswire)
21.02.22	Meridian Bioscience Appoints Andy Kitzmiller As CFO (RTTNews)
21.02.22	Meridian Bioscience Names Andy Kitzmiller as Chief Financial Officer (PR Newswire)
16.02.22	Magellan Diagnostics Resumes Distribution of LeadCare® II Test Kits (PR Newswire)
04.02.22	MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY (PR Newswire)
03.02.22	Ausblick: Meridian Bioscience zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
31.01.22	Meridian Bioscience Receives Additional NIH Award to Support the Rapid Development of the Revogene® Molecular Viral Respiratory Testing Panel (PR Newswire)
28.01.22	Meridian Bioscience Launches Lyo-Ready™ qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection (PR Newswire)
27.01.22	Meridian Bioscience Elects John C. McIlwraith New Chairman of the Board (PR Newswire)
20.01.22	Erste Schätzungen: Meridian Bioscience informiert über die jüngsten Quartalsergebnisse (finanzen.net)
10.01.22	Meridian Bioscience to Hold First Quarter 2022 Financial Results Conference Call on February 4, 2022 (PR Newswire)
05.01.22	Meridian Bioscience Receives FDA-Clearance for the Curian® Campy Assay (PR Newswire)
04.01.22	Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference (PR Newswire)
02.12.21	Meridian Bioscience Announces Retirement of CFO Bryan Baldasare (PR Newswire)
24.11.21	Meridian Bioscience Announces Retirement of Chairman David Phillips (PR Newswire)
17.11.21	Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing (PR Newswire)
12.11.21	Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance (PR Newswire)
11.11.21	Ausblick: Meridian Bioscience stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Meridian Bioscience Inc.

Aktien Top/Flop

Meistgelesene Nachrichten